SE9101381D0 - Peptide hormone solution - Google Patents

Peptide hormone solution

Info

Publication number
SE9101381D0
SE9101381D0 SE9101381A SE9101381A SE9101381D0 SE 9101381 D0 SE9101381 D0 SE 9101381D0 SE 9101381 A SE9101381 A SE 9101381A SE 9101381 A SE9101381 A SE 9101381A SE 9101381 D0 SE9101381 D0 SE 9101381D0
Authority
SE
Sweden
Prior art keywords
hormone
peptide hormone
hormone solution
solution
peptide
Prior art date
Application number
SE9101381A
Other languages
English (en)
Inventor
Tomas Moks
Original Assignee
Tomas Moks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tomas Moks filed Critical Tomas Moks
Priority to SE9101381A priority Critical patent/SE9101381D0/sv
Publication of SE9101381D0 publication Critical patent/SE9101381D0/sv
Priority to PCT/SE1992/000283 priority patent/WO1992019260A1/en

Links

SE9101381A 1991-05-07 1991-05-07 Peptide hormone solution SE9101381D0 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE9101381A SE9101381D0 (sv) 1991-05-07 1991-05-07 Peptide hormone solution
PCT/SE1992/000283 WO1992019260A1 (en) 1991-05-07 1992-04-29 Peptide hormone solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101381A SE9101381D0 (sv) 1991-05-07 1991-05-07 Peptide hormone solution

Publications (1)

Publication Number Publication Date
SE9101381D0 true SE9101381D0 (sv) 1991-05-07

Family

ID=20382669

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9101381A SE9101381D0 (sv) 1991-05-07 1991-05-07 Peptide hormone solution

Country Status (2)

Country Link
SE (1) SE9101381D0 (sv)
WO (1) WO1992019260A1 (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003002136A2 (en) 2001-06-28 2003-01-09 Novo Nordisk A/S Stable formulation of modified glp-1
ES2380437T3 (es) 2003-06-03 2012-05-11 Novo Nordisk A/S Composiciones farmacéuticas de péptido GLP-1 estabilizadas
WO2004105790A1 (en) 2003-06-03 2004-12-09 Novo Nordisk A/S Stabilized pharmaceutical peptide compositions
MXPA06005581A (es) * 2003-11-20 2006-08-11 Novo Nordisk As Formulaciones de peptidos que contienen propilenglicol que son optimas para la produccion y uso en dispositivos de inyeccion.
ES2442223T3 (es) 2004-08-31 2014-02-10 Novo Nordisk A/S Uso de tris(hidroximetil) aminometano para la estabilización de péptidos, polipéptidos y proteínas
WO2006051110A2 (en) 2004-11-12 2006-05-18 Novo Nordisk A/S Stable formulations of insulinoptropic peptides
WO2011051486A2 (en) 2009-11-02 2011-05-05 Novo Nordisk A/S Pharmaceutical solution of non covalently bound albumin and acylated insulin
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
WO2014096440A2 (en) 2012-12-21 2014-06-26 Novozymes Biopharma Dk A/S Composition
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
EP3050023B1 (en) 2014-10-27 2021-08-25 Aseko, Inc. Subcutaneous outpatient management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
WO2017031440A1 (en) 2015-08-20 2017-02-23 Aseko, Inc. Diabetes management therapy advisor
TWI783890B (zh) 2017-08-24 2022-11-11 丹麥商諾佛 儂迪克股份有限公司 Glp-1組成物及其用途
KR20220143037A (ko) 2020-02-18 2022-10-24 노보 노르디스크 에이/에스 Glp-1 조성물 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
CA1196863A (en) * 1983-06-08 1985-11-19 Mattheus F.A. Goosen Slow release injectable insulin composition
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina
JPH0341033A (ja) * 1989-07-07 1991-02-21 Kyowa Hakko Kogyo Co Ltd 安定なモチリン類含有製剤

Also Published As

Publication number Publication date
WO1992019260A1 (en) 1992-11-12

Similar Documents

Publication Publication Date Title
SE9101381D0 (sv) Peptide hormone solution
ES2526707T3 (es) Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos
ES2114183T3 (es) Anticuerpo para el tratamiento de la diabetes dependiente de la insulina.
SE8101065L (sv) Antitrombinberedning
JPS5536457A (en) Amino acid infusion
DE69220808D1 (de) Vorrichtung zur verabreichung von heilmitteln
DK0607156T3 (da) Fremgangsmåde til fremstilling af konserverede lægemidler indeholdende humane proteiner til infusions- eller injektionsformål
DE3686654T2 (de) Verfahren zur isolierung rekombinanter polypeptide in biologisch aktiver form.
ATE120374T1 (de) Markierte polypeptidderivate.
DK0526544T3 (da) Terapeutiske anvendelser af actinbindende forbindelser
DE69131847T2 (de) Verwendung von kupfer enthaltenden wirkstoffen zur beschleunigung der wundheilung
RU93053497A (ru) Новые пептиды-агонисты и их использование
EP0747092A3 (en) Dissolution liquid for drug in iontophoresis
ATE101650T1 (de) Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern.
DK0650729T3 (da) Rapamycin-præparater til intravenøs injektion
IT8220921A0 (it) Soluzione per dialisi contenente glucosio, aminoacidi e insulina.
DK0430200T3 (da) Polypeptidholdigt lægemiddel til subkutan eller intramuskulær applikation
UA26375A1 (uk) Спосіб очищеhhя іhсуліhу
DE59206619D1 (de) Wässrige Peritonealdialyse-Lösung
RU93004696A (ru) Способ адсорбции с применением таннина
ATE86627T1 (de) Isolierung von bioaktivem, monomerem wachstumshormon.
ES2055761T3 (es) Procedimiento para la concentracion de los factores de coagulacion de la sangre ii, vii, ix y x.
DE69322268D1 (de) Stabile zusammensetzung von polypeptiden
ATE149834T1 (de) Pyridylguanidine verbindungen zur behandlung von erektionsstörungen
SE8704849L (sv) Bruksferdiga injektionslosningar innehallande en antitumorantracyklinglykosid